Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice.
The ability of clinical isolates of Candida albicans and candida tropicalis to invade through normal and damaged gastrointestinal mucosa was determined. Adult mice were treated with either gentamicin or gentamicin and cytarabine. Suspensions of yeast cells (10(7)) were administered through a catheter intraesophageally. Invasion was determined by culturing liver, kidney, and lung tissue from mice sacrificed after 48 h. C. albicans and C. tropicalis were incapable of invading through normal gastrointestinal mucosa in mice treated only with gentamicin. Two isolates of C. tropicalis penetrated the damaged gastrointestinal mucosa in 69% (49 of 71) of mice treated with gentamicin and cytarabine. In contrast, three isolates of C. albicans penetrated he damaged gastrointestinal mucosa in only 23% (14 of 62) of mice. These results suggest that C. tropicalis is more capable of invading through damaged gastrointestinal mucosa than C. albicans. The observations in this mouse model parallel those seen in patients on cytotoxic drugs. Therefore, this model offers a tool for investigation of the pathogenicity of these organisms in a model analogous to the compromised host.
D000818:Animals; D002175:Candida / Q000472:pathogenicity*; D002176:Candida albicans / Q000472:pathogenicity; D003561:Cytarabine / Q000494:pharmacology; D005260:Female; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology; D005839:Gentamicins / Q000494:pharmacology; D007121:Immunocompetence; D007413:Intestinal Mucosa / Q000382:microbiology / Q000473:pathology; D051379:Mice; D011112:Polymyxin B / Q000494:pharmacology
D005839:Gentamicins; D003561:Cytarabine; D011112:Polymyxin B